PharVision Advisers’s Myers Industries MYE Stock Holding History

PharVision Advisers’s Portfolio MYE Stock Details MYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,030	Closed	-$288K	–	897
2025 Q3	$288K	Buy	+17,030	New	+$270K	0.16%	248

Other funds holding MYE

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's MYE Position: Q4 2025 in Review

PharVision Advisers sold out of Myers Industries (MYE) in Q4 2025, closing a stake of 17,030 shares — an estimated $288K sold.

PharVision Advisers first reported a position in MYE in Q3 2025 and held it in 1 quarter. The position peaked at $288K in Q3 2025. 173 funds tracked by Wall St. Rank hold MYE as of Q4 2025.

PharVision Advisers reported no remaining Myers Industries position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 17,030 Myers Industries shares in Q4 2025, an estimated $288K.
PharVision Advisers first reported a position in Myers Industries in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Myers Industries position peaked at $288K in Q3 2025.
173 funds tracked by Wall St. Rank held Myers Industries as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.